Taro Pharmaceutical Industries Ltd $106.46

up +1.55


17/4/2014 06:40 PM  |  NYSEARCA : TARO  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get TARO Trend Analysis - it has outperformed the S&P 500 by 63%

Partner Headlines

  1. Mylan Bid Gets Rejected, But Generic-Drugmaker Rises

    IBD
  2. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  3. Caesarstone, Check Point Show Strong Fundamentals

    IBD
  4. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  5. Ascending Bases Are Rare, But Can Spark Big Gains

    IBD
  6. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  7. Generic-Drug Makers Actavis, Mylan To Report Q4 Soon

    IBD
  8. Actavis, Perrigo Pace Strong Generic Drugs Group

    IBD
  9. Top Funds Like Facebook And Health Care Stocks

    IBD
  10. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  11. US Stock Futures Up Ahead Of Pending Home Sales

    Benzinga
  12. Taro Commences Tender Offer to Buybackup Up to $200M of Ordinary Shares ...

    Benzinga
  13. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  14. UPDATE: Credit Suisse Initiates Coverage on Taro Pharmaceutical on Market ...

    Benzinga
  15. Drug Firm Actavis Eyes Growth From A Buyout, Lidoderm

    IBD
  16. Actavis, Warner Chilcott Take Another Step Forward

    IBD
  17. Taro to Defer Annual General Meeting to September 12, 2013

    Benzinga
  18. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  19. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  20. Generic Drugs: Watson Up, Impax Awaits FDA Decision

    IBD
  21. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  22. BlueMountain Capital Says Shareholders of Taro Should Reject Sun Offer

    Benzinga
  23. Taro Special Committee Rejects Proposal from Sun Pharma

    Benzinga
  24. Taro Pharmaceutical Shareholder, Guardian Point Capital, Issues Letter ...

    Benzinga
  25. Mellanox, Several Other Israeli Stocks Show Strength

    IBD
  26. Taro Special Committee Continues to Evaluate Sun Pharma's Proposal to Acquire ...

    Benzinga
  27. IsZo Capital Calls upon Special Committee of Taro Pharmaceutical to Reject ...

    Benzinga
  28. Israel's Best-Rated Stocks Show Growth Plenty Of Problems

    IBD
Trading Center